Rematib Tablet 15 mg contains Upadacitinib, a selective Janus kinase (JAK) inhibitor used in the management of moderate to severe autoimmune and inflammatory disorders. It is primarily prescribed for patients who have shown inadequate response or intolerance to conventional therapies. By targeting specific pathways involved in inflammation, Rematib helps reduce disease activity, relieve symptoms, and improve overall quality of life.

Upadacitinib is recognized for its targeted mechanism, offering effective control of chronic inflammatory conditions with convenient once-daily oral dosing.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Upadacitinib 15 mg per tablet

Mechanism of Action

Upadacitinib selectively inhibits Janus kinase (JAK) enzymes, particularly JAK1, which play a critical role in the signaling pathways of various pro-inflammatory cytokines. By blocking these signaling pathways, Rematib reduces immune-mediated inflammation and helps control symptoms such as joint pain, swelling, stiffness, and tissue damage associated with autoimmune diseases.

This targeted inhibition allows for effective suppression of inflammatory responses while minimizing broader immune system suppression.

Indications

Rematib Tablet 15 mg is indicated for:

• Moderate to severe rheumatoid arthritis

• Psoriatic arthritis

• Ankylosing spondylitis

• Atopic dermatitis (moderate to severe)

• Other approved inflammatory conditions as prescribed by a physician

It is generally used in patients who have not responded adequately to disease-modifying antirheumatic drugs (DMARDs) or biologic therapies.

Dosage and Administration

The usual recommended dose is 15 mg once daily, or as directed by a healthcare professional. The tablet should be swallowed whole with water and may be taken with or without food. It should not be crushed or chewed.

Before starting treatment, patients may require screening for infections such as tuberculosis and regular laboratory monitoring during therapy. Dosage adjustments may be necessary in certain clinical situations.

Benefits

• Reduces inflammation and joint damage

• Relieves pain, swelling, and stiffness

• Improves physical function and mobility

• Convenient once-daily oral administration

• Targeted mechanism for better disease control

Precautions

Rematib should be used with caution in patients with a history of recurrent infections, liver impairment, cardiovascular risk factors, or blood disorders. Because JAK inhibitors can increase the risk of serious infections, thrombosis, and certain malignancies, regular medical supervision is essential.

Live vaccines should generally be avoided during treatment. Women who are pregnant, planning pregnancy, or breastfeeding should consult a healthcare provider before use.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Upper respiratory tract infections

• Nausea

• Elevated liver enzymes

• Headache

• Acne

Serious adverse effects such as severe infections, blood clots, or allergic reactions require immediate medical attention.

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Rematib Tablet 15 mg offers an advanced oral treatment option for managing chronic inflammatory diseases, helping patients achieve better symptom control and improved daily functioning under proper medical guidance.